256 related articles for article (PubMed ID: 21784845)
1. Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.
Morrison C; Mancini S; Cipollone J; Kappelhoff R; Roskelley C; Overall C
J Biol Chem; 2011 Sep; 286(39):34271-85. PubMed ID: 21784845
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
3. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
[TBL] [Abstract][Full Text] [Related]
4. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.
Thiolloy S; Edwards JR; Fingleton B; Rifkin DB; Matrisian LM; Lynch CC
PLoS One; 2012; 7(1):e29862. PubMed ID: 22238668
[TBL] [Abstract][Full Text] [Related]
5. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
Du WW; Fang L; Yang W; Sheng W; Zhang Y; Seth A; Yang BB; Yee AJ
BMC Cancer; 2012 Aug; 12():341. PubMed ID: 22862967
[TBL] [Abstract][Full Text] [Related]
6. The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.
Morrissey C; Lai JS; Brown LG; Wang YC; Roudier MP; Coleman IM; Gulati R; Vakar-Lopez F; True LD; Corey E; Nelson PS; Vessella RL
Prostate; 2010 Mar; 70(4):412-24. PubMed ID: 19866469
[TBL] [Abstract][Full Text] [Related]
7. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.
Nannuru KC; Futakuchi M; Varney ML; Vincent TM; Marcusson EG; Singh RK
Cancer Res; 2010 May; 70(9):3494-504. PubMed ID: 20406980
[TBL] [Abstract][Full Text] [Related]
9. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
[TBL] [Abstract][Full Text] [Related]
10. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
11. The effect of Neovastat (AE-941) on an experimental metastatic bone tumor model.
Weber MH; Lee J; Orr FW
Int J Oncol; 2002 Feb; 20(2):299-303. PubMed ID: 11788892
[TBL] [Abstract][Full Text] [Related]
12. Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
Chen YC; Sosnoski DM; Gandhi UH; Novinger LJ; Prabhu KS; Mastro AM
Carcinogenesis; 2009 Nov; 30(11):1941-8. PubMed ID: 19759193
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells.
Ibaragi S; Shimo T; Iwamoto M; Hassan NM; Kodama S; Isowa S; Sasaki A
Anticancer Res; 2010 Dec; 30(12):5029-36. PubMed ID: 21187486
[TBL] [Abstract][Full Text] [Related]
14. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.
Fong JE; Le Nihouannen D; Komarova SV
J Biol Chem; 2010 Oct; 285(41):31427-34. PubMed ID: 20679341
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation.
Zunich SM; Valdovinos M; Douglas T; Walterhouse D; Iannaccone P; Lamm ML
Mol Cancer; 2012 Jul; 11():30. PubMed ID: 22559324
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
Chiovaro F; Martina E; Bottos A; Scherberich A; Hynes NE; Chiquet-Ehrismann R
Int J Cancer; 2015 Oct; 137(8):1842-54. PubMed ID: 25868708
[TBL] [Abstract][Full Text] [Related]
18. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
[TBL] [Abstract][Full Text] [Related]
20. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
Rucci N; Millimaggi D; Mari M; Del Fattore A; Bologna M; Teti A; Angelucci A; Dolo V
Cancer Res; 2010 Aug; 70(15):6150-60. PubMed ID: 20631064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]